# SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)

> **NCT03806452** · PHASE2 · COMPLETED · sponsor: **Theravia** · enrollment: 86 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Hydroxycarbamide
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03806452
- **Lead sponsor:** Theravia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-28
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-05-30
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2025-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03806452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03806452, "SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03806452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*